Signpath Pharma Inc

(SGTH)

By |

Profile

SignPath Pharma Inc is a clinical biotechnology company. It develops synthesized proprietary formulations of curcumin for applications in human diseases. The company is developing products to treat cancer, neurologic disorders, and drug-induced cardiac arrhythmia. Its patent portfolio includes Intravenous infusion of curcumin and a calcium channel blocker and liposomal curcumin for treatment of diseases.

Contact Information

Website: www.signpathpharma.com
Main Phone: +1 215 538-9996
Address: 3477 Corporate Parkway
Address 2: Suite 100
State: PA
City / Town: Center Valley
Country: USA
Postal Code: 18034

Issuer Information

Exchange: OTO
CEO: Lawrence Helson
Employees: 2
NAICS: Pharmaceutical Preparation Manufacturing(325412)